Initial effects of COVID-19 on patients with end-stage kidney disease
1. Patients with end-stage kidney disease were at increased risk of COVID-19-related mortality, particularly among non-Hispanic Black patients.
Evidence Rating Level: 3 (Average)
End-stage kidney disease...
Mood disorders and outcomes of COVID-19 hospitalizations
1. Mood disorder diagnoses prior to hospitalization for COVID-19 was associated with increased risk of in-hospital mortality after Day 12.
2. Prior mood disorders were...
Post-COVID syndrome associated with significant morbidity and mortality beyond respiratory illnesses
1. Hospital readmission and all-cause mortality rates are 3.5 and 7.7 times higher in COVID-19 patients after discharge, than the general population.
2. In addition...
Tislelizumab plus chemotherapy vs chemotherapy alone as treatment for advanced squamous NSCLC
1. Tislelizumab, a monoclonal antibody and PD1/L1 inhibitor, when combined with chemotherapy, showed significantly prolonged progression free survival and higher objective response rate, compared...
3 days of β-lactam therapy is non-inferior to 8 days of therapy among patients...
1. Cure at 15 days occurred in 77% of patients in the placebo (3-day therapy) group compared to 68% of patients in the β-lactam...
Reinfection rates among patients previously testing positive for COVID-19
1. Among a large U.S. cohort, previous infection with SARS-CoV-2 appears to confer high levels of immunity against reinfection for at least 8 months.
Evidence...
4PEPS clinical probability score may reduce need for imaging in suspected pulmonary embolism
1. The 4PEPs strategy (4-Level Pulmonary Embolism Clinical Probability Score) may be a useful tool for emergency department physicians in patients suspected of pulmonary...
Sex differences in ischemic stroke outcomes in patients with pulmonary hypertension
1. Pulmonary hypertension (PH) was associated with a 15% increase in odds of prolonged hospitalization.
2. PH was associated with a 31% decrease in odds...
Attributes and predictors of long COVID
1. Those testing positive for COVID-19 and experiencing five or more symptoms during the first week had greater odds of having a symptom duration...
Everolimus treatment effective for improving renal function in lung transplant patients
1. Lung transplant patients showed improved renal function and reduced immunosuppressant dosage after twelve months of everolimus treatment.
2. Patients with chronic lung allograft dysfunction...
